Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Analysis of clinical data using neural nets

J M Minor1, H Namini

  • 1Amgen Inc., Thousand Oaks, California 91320, USA.

Journal of Biopharmaceutical Statistics
|March 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C.

Journal of viral hepatitis·2006
Same author

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study.

Lancet (London, England)·2001
Same author

Assessment of hepatitis C virus RNA stability in serum by the Quantiplex branched DNA assay.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·1999
Same author

Effect of multiple freeze-thaw cycles on hepatitis B virus DNA and hepatitis C virus RNA quantification as measured with branched-DNA technology.

Journal of clinical microbiology·1999
Same author

Statistical models for predicting a beneficial response to interferon-alpha in patients with chronic hepatitis B.

Journal of viral hepatitis·1998
Same author

Assessment of hepatitis B virus DNA stability in serum by the Chiron Quantiplex branched-DNA assay.

Journal of clinical microbiology·1998
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

Neural networks can model complex relationships between drug dosing, pharmacokinetics (PK), and treatment efficacy. This approach aids in understanding drug effects and designing better clinical trials with limited data.

Area of Science:

  • Pharmacometrics
  • Computational Biology
  • Clinical Pharmacology

Background:

  • Clinical studies explore the intricate links between drug dosing, efficacy, and side effects, often involving complex dynamics.
  • Understanding intermediate processes like pharmacokinetics (PK) is crucial for deciphering these interdependencies.
  • Efficacy is a complex function of PK parameters, which are increasingly influenced by sophisticated drug regimens and delivery systems.

Purpose of the Study:

  • To investigate the application of neural networks in modeling complex dynamical functions in clinical pharmacology.
  • To explore how neural networks can identify and model the relationships between dosing, PK, and efficacy with limited data.
  • To assess the utility of neural networks in optimizing clinical trial design for complex therapeutic strategies.

Related Experiment Videos

Main Methods:

  • Utilized stationary and time-dependent neural networks to model unknown complex dynamical functions.
  • Applied neural networks to analyze relationships between dosing, PK parameters, and treatment efficacy.
  • Leveraged machine learning techniques to handle complex associations among treatments, pharmacodynamics, efficacy, and side effects.

Main Results:

  • Neural networks effectively modeled complex dynamical functions with minimal assumptions and limited data.
  • Demonstrated the capability of neural networks to directly link dosing to efficacy, dosing to PK, and PK to efficacy.
  • Showcased the potential of neural networks in analyzing intricate associations within treatment response.

Conclusions:

  • Neural networks offer a powerful tool for understanding and modeling complex dose-response relationships in clinical studies.
  • This approach can simplify the analysis of pharmacokinetics and pharmacodynamics, even with sophisticated drug regimens.
  • Neural networks can significantly aid in the design and execution of advanced clinical trials, improving efficiency and insight.